Sector revisions Caplin Point Laboratories Limited NSE India S.E.

Stocks

Delayed NSE India S.E. Other stock markets 06:11:54 2026-07-10 EDT			5-day change	1st Jan Change
2,583.60 ^INR	-1.44%		+1.79%	+40.56%

05-14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
SUN PHARMACEUTICAL INDUSTRIES LTD.					34
OTSUKA HOLDINGS CO., LTD.					12
CIPLA LIMITED					37
ZYDUS LIFESCIENCES LIMITED					31
KRKA, D. D.					6
ONO PHARMACEUTICAL CO., LTD.					12
GEDEON RICHTER					7
GLENMARK PHARMACEUTICALS LIMITED					11
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.				-	-
AJANTA PHARMA LIMITED					14
ASPEN PHARMACARE HOLDINGS LIMITED					4
SIMCERE PHARMACEUTICAL GROUP LIMITED					5
JAMJOOM PHARMACEUTICALS FACTORY COMPANY					3
HAW PAR CORPORATION LIMITED		-	-	-	1
ASTRA INDUSTRIAL GROUP COMPANY				-	1
SUNSHINE LAKE PHARMA CO., LTD.	-	-		-	-
APICHOPE PHARMACEUTICAL GROUP CO., LTD.				-	-
Average					13
Weighted average by Cap.					21